{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:20Z","timestamp":1792601480819,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20180278"],"award-info":[{"award-number":["20180278"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02760"],"award-info":[{"award-number":["2018-02760"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Emerg Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a leading cause of death worldwide and a major challenge for physicians to predict and manage. Proenkephalin A 119\u2013159 (penKid) is a reliable surrogate marker for the more unstable endogenous opioid peptide enkephalin, which has previously been shown to predict both acute and chronic kidney disease. The aim of this prospective observational study was to assess penKid as a predictor of acute kidney injury (AKI), multi-organ failure and mortality in sepsis among unselected sepsis patients presenting to the emergency department (ED).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We enrolled 644 patients consecutively during office-hours (6\u2009AM-6\u2009PM) between December 1, 2013 and February 1, 2015. Fifty-six patients were excluded due to incomplete data. We measured penKid in 588 adult patients (patients under 18\u2009years of age were excluded) with sepsis (\u22652SIRS criteria + suspected infection) upon admission to the ED at Sk\u00e5ne University Hospital, Malm\u00f6, Sweden. Logistic regression analysis was used to relate levels of penKid at presentation to AKI, multi-organ failure, 28-day mortality and progression of renal SOFA subscore. Odds ratios are presented as the number of standard deviations from the mean of log-transformed penKid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In age and sex adjusted models, penKid predicted AKI within 48\u2009h and 7\u2009days, but these associations were attenuated after additional adjustment for estimated creatinine-based glomerular filtration rate (eGFR). In models adjusted for age, sex and eGFR, penKid significantly predicted progression from rSOFA\u2009=\u20090 and\u2009\u2264\u20091 to higher rSOFA scores as well as multi-organ failure and mortality. In contrast, eGFR did not predict 28-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PenKid is an effective predictor of renal injury, severe multi-organ failure and mortality in unselected sepsis patients presenting to the emergency department.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12873-019-0283-9","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T13:03:12Z","timestamp":1574946192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Proenkephalin a 119\u2013159 (penKid) \u2013 a novel biomarker for acute kidney injury in sepsis: an observational study"],"prefix":"10.1186","volume":"19","author":[{"given":"Mari","family":"Rosenqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-2655","authenticated-orcid":false,"given":"Kevin","family":"Bronton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"issue":"8","key":"283_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801.","journal-title":"JAMA"},{"issue":"1","key":"283_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semnephrol.2015.01.002","volume":"35","author":"R Alobaidi","year":"2015","unstructured":"Alobaidi R, Basu RK, Goldstein SL, Bagshaw SM. Sepsis-associated acute kidney injury. Semin Nephrol. 2015;35(1):2\u201311.","journal-title":"Semin Nephrol"},{"issue":"3","key":"283_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2215\/CJN.03681106","volume":"2","author":"SM Bagshaw","year":"2007","unstructured":"Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2(3):431\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"283_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","volume":"43","author":"R Bellomo","year":"2017","unstructured":"Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816\u201328.","journal-title":"Intensive Care Med"},{"issue":"4 Suppl","key":"283_CR5","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1097\/CCM.0b013e318168ccd5","volume":"36","author":"L Wan","year":"2008","unstructured":"Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36(4 Suppl):S198\u2013203.","journal-title":"Crit Care Med"},{"issue":"1","key":"283_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ckj\/sfs160","volume":"6","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Jorge S. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J. 2013;6(1):8\u201314.","journal-title":"Clin Kidney J"},{"issue":"1","key":"283_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semnephrol.2017.09.002","volume":"38","author":"DG Moledina","year":"2018","unstructured":"Moledina DG, Parikh CR. Phenotyping of acute kidney injury: beyond serum Creatinine. Semin Nephrol. 2018;38(1):3\u201311.","journal-title":"Semin Nephrol"},{"issue":"1","key":"283_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13054-016-1373-7","volume":"20","author":"C Ronco","year":"2016","unstructured":"Ronco C. Acute kidney injury: from clinical to molecular diagnosis. Critical Care. 2016;20(1):201.","journal-title":"Critical Care"},{"issue":"1","key":"283_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.peptides.2007.11.004","volume":"29","author":"GM Denning","year":"2008","unstructured":"Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, et al. Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides. 2008;29(1):83\u201392.","journal-title":"Peptides"},{"issue":"1","key":"283_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1681\/ASN.2015101177","volume":"28","author":"C-A Schulz","year":"2017","unstructured":"Schulz C-A, Christensson A, Ericson U, Almgren P, Hindy G, Nilsson PM, et al. High level of fasting plasma Proenkephalin-a predicts deterioration of kidney function and incidence of CKD. J Am Soc Nephrol. 2017;28(1):291\u2013303.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"283_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3343\/alm.2017.37.5.388","volume":"37","author":"H Kim","year":"2017","unstructured":"Kim H, Hur M, Lee S, Marino R, Magrini L, Cardelli P, et al. Proenkephalin, neutrophil Gelatinase-associated Lipocalin, and estimated glomerular filtration rates in patients with Sepsis. Ann Lab Med. 2017;37(5):388\u201397.","journal-title":"Ann Lab Med"},{"issue":"1","key":"283_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jacc.2016.10.038","volume":"69","author":"LL Ng","year":"2017","unstructured":"Ng LL, Squire IB, Jones DJL, Cao TH, Chan DCS, Sandhu JK, et al. Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study. J Am Coll Cardiol. 2017;69(1):56\u201369.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"283_CR13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/ijms18081662","volume":"18","author":"Jana Mossanen","year":"2017","unstructured":"Mossanen JC, Pracht J, Jansen TU, Buendgens L, Stoppe C, Goetzenich A, et al. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery. Int J Mol Sci. 2017;18(8). https:\/\/doi.org\/10.3390\/ijms18081662.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"283_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5414\/CN108387","volume":"83","author":"KS Shah","year":"2015","unstructured":"Shah KS, Taub P, Patel M, Rehfeldt M, Struck J, Clopton P, et al. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clin Nephrol. 2015;83(1):29\u201335.","journal-title":"Clin Nephrol"},{"issue":"9","key":"283_CR15","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1373\/clinchem.2018.288068","volume":"64","author":"P Caironi","year":"2018","unstructured":"Caironi P, Latini R, Struck J, Hartmann O, Bergmann A, Bellato V, et al. Circulating Proenkephalin, acute kidney injury, and its improvement in patients with severe Sepsis or shock. Clin Chem. 2018;64(9):1361\u20139.","journal-title":"Clin Chem"},{"key":"283_CR16","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.ekir.2018.08.006","volume":"3","author":"A Hollinger","year":"2018","unstructured":"Hollinger A, Wittebole X, Fran\u00e7ois B, Pickkers P, Antonelli M, Gayat E, et al. Proenkephalin a 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the kidney in Sepsis and septic shock (kid-SSS) study. Kidney Int Rep. 2018;3:1424.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"283_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s40620-014-0163-z","volume":"28","author":"R Marino","year":"2015","unstructured":"Marino R, Struck J, Hartmann O, Maisel AS, Rehfeldt M, Magrini L, et al. Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department. J Nephrol. 2015;28(6):717\u201324.","journal-title":"J Nephrol"},{"issue":"6","key":"283_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"4","key":"283_CR19","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international Sepsis definitions conference. Crit Care Med. 2003;31(4):1250\u20136.","journal-title":"Crit Care Med"},{"issue":"2","key":"283_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165\u2013228.","journal-title":"Intensive Care Med"},{"issue":"6","key":"283_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/cc3009","volume":"8","author":"MM Levy","year":"2004","unstructured":"Levy MM. The challenge of sepsis. Crit Care. 2004;8(6):435\u20136.","journal-title":"Crit Care"},{"issue":"1","key":"283_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5935\/0103-507X.20170002","volume":"29","author":"AH Carneiro","year":"2017","unstructured":"Carneiro AH, Povoa P, Gomes JA. Dear Sepsis-3, we are sorry to say that we don't like you. Rev Bras Ter Intensiva. 2017;29(1):4\u20138.","journal-title":"Rev Bras Ter Intensiva"},{"key":"283_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13017-018-0165-6","volume":"13","author":"M Sartelli","year":"2018","unstructured":"Sartelli M, Kluger Y, Ansaloni L, Hardcastle TC, Rello J, Watkins RR, et al. Raising concerns about the Sepsis-3 definitions. World J Emerg Surg. 2018;13:6.","journal-title":"World J Emerg Surg"}],"container-title":["BMC Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-019-0283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12873-019-0283-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-019-0283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T19:12:25Z","timestamp":1606417945000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcemergmed.biomedcentral.com\/articles\/10.1186\/s12873-019-0283-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1186\/s12873-019-0283-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13581\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13581\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13581\/v3","asserted-by":"object"}]},"ISSN":["1471-227X"],"issn-type":[{"value":"1471-227X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethical Review Board in Lund, Lund University, Sweden (2013\/635) and conducted in accordance with the Helsinki Declaration. Both written and oral informed consent was obtained from all patients or their next of kin after they had the opportunity to read and review a written description of the study design and purpose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.B. has shares in and is CEO of Sphingotec GmbH, the company providing and having the patent rights on the penKid assay and its use for the prediction\/diagnosis of AKI. J.S. and OH are employees of Sphingotec GmbH. The other authors report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}